Shilpa Medicare Limited (BOM:530549)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Active Pharmaceutical Ingredients	7.30B
Active Pharmaceutical Ingredients Growth	1.92%
Contract Development and Manufacturing Organization / License Fee	2.16B
Contract Development and Manufacturing Organization / License Fee Growth	159.89%
Formulations	1.90B
Formulations Growth	-7.61%
Other	148.23M
Other Growth	-0.18%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
India	5.39B
India Growth	5.65%
Europe	2.34B
Europe Growth	10.02%
United States	2.31B
United States Growth	40.64%
Rest of World	1.47B
Rest of World Growth	-9.43%